Richard A. Burkhart et al. [89] found that mitoxantrone target USP11, a potential inhibitor of pancreatic cancer cell survival, implying that USP11 promotes the progression of pancreatic cancer and is a natural therapeutic target (Fig. 4). The gene discussed is USP11; the disease is pancreatic neoplasm.